Int. J. Mol. Sci. 2013, 14(4), 6690-6719; doi:10.3390/ijms14046690
Review

Aptamers and Their Potential to Selectively Target Aspects of EGF, Wnt/β-Catenin and TGFβ–Smad Family Signaling

Laboratory of Molecular Biology (Celgen), Department of Development and Regeneration, KU Leuven, Campus Gasthuisberg, Building Ond & Nav4 p.o.box 812, room 05.313, Stem Cell Institute, Herestraat 49, B-3000 Leuven, Belgium
* Author to whom correspondence should be addressed.
Received: 15 February 2013; in revised form: 5 March 2013 / Accepted: 12 March 2013 / Published: 26 March 2013
(This article belongs to the Special Issue Signalling Molecules and Signal Transduction in Cells)
PDF Full-text Download PDF Full-Text [2586 KB, Updated Version, uploaded 8 April 2013 17:37 CEST]
The original version is still available [2583 KB, uploaded 26 March 2013 11:24 CET]
Abstract: The smooth identification and low-cost production of highly specific agents that interfere with signaling cascades by targeting an active domain in surface receptors, cytoplasmic and nuclear effector proteins, remain important challenges in biomedical research. We propose that peptide aptamers can provide a very useful and new alternative for interfering with protein–protein interactions in intracellular signal transduction cascades, including those emanating from activated receptors for growth factors. By their targeting of short, linear motif type of interactions, peptide aptamers have joined nucleic acid aptamers for use in signaling studies because of their ease of production, their stability, their high specificity and affinity for individual target proteins, and their use in high-throughput screening protocols. Furthermore, they are entering clinical trials for treatment of several complex, pathological conditions. Here, we present a brief survey of the use of aptamers in signaling pathways, in particular of polypeptide growth factors, starting with the published as well as potential applications of aptamers targeting Epidermal Growth Factor Receptor signaling. We then discuss the opportunities for using aptamers in other complex pathways, including Wnt/β-catenin, and focus on Transforming Growth Factor-β/Smad family signaling.
Keywords: aptamers; β-catenin; EGF; signal transduction; Smad-interacting proteins; Smad; TGFβ; Wnt

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Conidi, A.; van den Berghe, V.; Huylebroeck, D. Aptamers and Their Potential to Selectively Target Aspects of EGF, Wnt/β-Catenin and TGFβ–Smad Family Signaling. Int. J. Mol. Sci. 2013, 14, 6690-6719.

AMA Style

Conidi A, van den Berghe V, Huylebroeck D. Aptamers and Their Potential to Selectively Target Aspects of EGF, Wnt/β-Catenin and TGFβ–Smad Family Signaling. International Journal of Molecular Sciences. 2013; 14(4):6690-6719.

Chicago/Turabian Style

Conidi, Andrea; van den Berghe, Veronique; Huylebroeck, Danny. 2013. "Aptamers and Their Potential to Selectively Target Aspects of EGF, Wnt/β-Catenin and TGFβ–Smad Family Signaling." Int. J. Mol. Sci. 14, no. 4: 6690-6719.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert